Roel Bulthuis – Startup Investor Profile

Roel Bulthuis, Managing Director at INKEF Capital, leads the Healthcare investment team. With over 15 years of experience in venture capital, pharma business development, and investment banking, Roel’s track record includes roles as SVP and Managing Director at M-Ventures and positions in global business development at Merck Serono. His investment focus areas include Pharmaceuticals (Series A and B), Digital Health (Series A and B), BioTech (Series A and B), Health & Hospital Services (Series A and B), and Health IT (Series A and B). Roel’s investments range from $100K to $5.0M, with a sweet spot at $1.5M. Noteworthy investments include QurAlis, NMD Pharma, Salvia BioElectronics, and VarmX. Additionally, Roel is known for his collaborative and innovative partnership style, aiming to change the status quo and foster growth in the healthcare sector.

Location: Amsterdam, Netherlands

Country: Netherlands

Investment Regions: EU, NA

Investment Stages: pre-seed, seed

Website: https://www.inkefcapital.com/team/

AI Reasoning: Evidence shows Roel Bulthuis moved from INKEF to Syncona in 2023 and has activity at Syncona (e.g., involvement in Syncona investments noted in 2023/2024 documents). The last publicly referenced investment related to his prior INKEF profile (e.g., Salvia BioElectronics, VarmX) dates to 2020. No public record of a new investment by Roel Bulthuis within the past 12 months was found; the most recent firm-level activity linked to him is 2023 job move and 2023/2024 Syncona mentions but no specific new investment after 2023. The last clear investment date found tied to him is 2020 (Salvia BioElectronics / VarmX), which is more than 12 months ago, therefore classify as not-active.

Low Activity – Only known angel investments more than 12 months ago.

Active – Known angel investments between the last 12 and 6 months.

Very Active – Known angel investments in the last 6 months.